AdisInsight: Drugs (formerly Adis R&D Insight) provides leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are tracked across all therapeutic areas and throughout the entire development process, from discovery to launch.
AdisInsight drug profiles include:
Key development milestones
Development status and history
Trial landscape and details
Related safety reports
Data is collected from more than 2,300 biomedical journals covering drugs and therapeutics, news services, newsletters, company annual reports, contact with companies, market intelligence, meetings and conferences.
Information reported in AdisInsight: Drugs includes:
Generic name, synonyms, brand names
Development phases by indication and country
Adverse events, pharmacology, pharmacokinetics, pharmacodynamics, therapeutic trials
Forecasts of approval probability, and revenue
AdisInsight profiles are also backed by more than 10,000 evaluated Adis scientific summaries and 63,000 bibliographic references.